2016 American Transplant Congress Archives - Page 25 of 180

6:00pm-7:00pm: Attenuation of Warm Hepatic Ischemia-Reperfusion Injury by Bruton's Tyrosine Kinase Inhibition.

A. Zarrinpar,¹ T. Palumbo,¹ K. Nakamura,¹ C. Lassman,² R. Busuttil,¹ J. Kupiec-Weglinski.¹

Poster Session C: Ischemia Reperfusion Injury and Organ Preservation • Halls C&D

6:00pm-7:00pm: Bariatric Surgery and Increased Risk of Death After Listing for Liver Transplantation.

S. Asrani, F. Khan, G. Saracino, G. McKenna, J. Hasse, G. Klintmalm, J. Trotter.

Poster Session C: Liver Transplantation Complications and Other Considerations • Halls C&D

6:00pm-7:00pm: Baseline Donor Specific Antibody (DSA) More Predictive of Chronic Antibody Mediated Rejection (CAMR) Than the Change in DSA Over Time.

D. Mitema,¹ W. Cheungpasitporn,¹ M. Stegall,¹ F. Cosio,¹ M. Gandhi,² C. Schinstock.¹

Poster Session C: Antibody Mediated Rejection: Session #1 • Halls C&D

6:00pm-7:00pm: Bioinformatic Analysis of Pathways Mediating Clusterin Functions in Kidney Cells Under Normoxia and Hypoxia.

G. Dairi, Q. Guan, C. Collins, C. Ong, M. Gleave, C. Nguan, C. Du.

Poster Session C: Ischemia Reperfusion Injury and Organ Preservation • Halls C&D

6:00pm-7:00pm: Breadth of HLA-Specific B Cell Reactivity and Frequency Assessed by a Novel Multiplex Bead Based Assay Predicts and Correlates with Rejection in Kidney Transplant Recipients.

A. Akl, Z. Ilyas, O. Traitanon, L. Gallon, A. Tambur, M. Ansari.

Poster Session C: Antibody Mediated Rejection: Session #1 • Halls C&D

6:00pm-7:00pm: C1-Inhibitor Abrogated Ischemia/Reperfusion (I/R) Induced Inflammaging by Inhibiting Senescence-Associated Secretory Phenotype (SASP) in Tubular Epithelial Cells (TEC).

G. Castellano,¹ R. Franzin,¹ A. Stasi,¹ C. Divella,¹ M. Gigante,¹ S. Simone,¹ A. Intini,¹ A. Picerno,¹ P. Pontrelli,¹ A. Crovace,¹ M. Battaglia,¹ B. Oortwijn,² E. Amersfoort,² G. Grandaliano,³ L. Gesualdo.¹

Poster Session C: Ischemia Reperfusion Injury and Organ Preservation • Halls C&D

6:00pm-7:00pm: Can Qrisk Be Useful to Predict Future Cardiovascular Co-Morbidites and Type II Diabetes in Living Kidney Donors Prior to Donation?

S. Bhutani, R. Chinnadurai, G. Bernal-Blanco, B. Patel, A. Summers, D. Van Dellen, M. Morton, P. Michael.

Poster Session C: Kidney Donor Evaluation and Donor Nephrectomy • Halls C&D

6:00pm-7:00pm: Cardiovascular Prognosis and Adverse Cardiac Events After Orthotopic Liver Transplantation.

L. Potena, V. Manfredini, P. Prestinenzi, R. Alabrese, V. Bertuzzo, L. Borgese, M. Masetti, C. Morelli, F. Grigioni, A. Pinna.

Poster Session C: Liver Transplantation Complications and Other Considerations • Halls C&D

6:00pm-7:00pm: Caval Replacement versus Piggyback Liver Transplantation: The Toronto Experience.

A. Barbas, M. Dib, N. Goldaracena, M. Marquez, G. Sapisochin, D. Al-Adra, S. McCluskey, I. McGilvray.

Poster Session C: Liver Transplantation Complications and Other Considerations • Halls C&D

6:00pm-7:00pm: Changes in Fatigue After Kidney Transplantation.

H. Ying, I. Olorundare, N. Dagher, B. Lonze, R. Montgomery, M. McAdams-Demarco, D. Segev.

Poster Session C: Poster Session 1: Kidney Complications-Other • Halls C&D